Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting

Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting

Doxorubicin (DOX), a widely used drug in cancer chemotherapy, induces cell death via multiple intracellular interactions, generating reactive oxygen species and DNA-adducted configurations that induce apoptosis, topoisomerase II inhibition, and histone eviction. Despite its wide therapeutic efficacy...

书目详细资料
Main Authors:	Jihoon Lee, Min-Koo Choi, Im-Sook Song
格式:	文件
语言:	English
出版:	MDPI AG 2023-05-01
丛编:	Pharmaceuticals
主题:	doxorubicin (DOX) formulation strategy drug resistance oral formulation
在线阅读:	https://www.mdpi.com/1424-8247/16/6/802

相似书籍

Molecular mechanisms associated with the chemoprotective role of protocatechuic acid and its potential benefits in the amelioration of doxorubicin-induced cardiotoxicity: A review
由: Edozie S. Okpara, et al.
出版: (2022-01-01)

UHPLC-MS/MS Assay for Quantification of Legubicin, a Novel Doxorubicin-Based Legumain-Activated Prodrug, and Its Application to Pharmacokinetic and Tissue Distribution Studies
由: Liyuan Ma, et al.
出版: (2024-02-01)

Salvage Chemotherapy in Recurrent Cervical Cancer With Biweekly Pegylated Liposomal Doxorubicin (Lipo-Dox)
由: Jen-Ruei Chen, et al.
出版: (2008-09-01)

Targeting mitochondrial dynamics proteins for the treatment of doxorubicin-induced cardiotoxicity
由: Rui Chen, et al.
出版: (2023-08-01)

Quantitative analysis of doxorubicin hydrochloride and arterolane maleate by mid IR spectroscopy using transmission and reflectance modes
由: Ranju Bansal, et al.
出版: (2021-04-01)

The influence of strategy formulation practices on the perceived financial performance of small and medium enterprises: The Zimbabwean experience
由: Mugove Mashingaidze, et al.
出版: (2021-05-01)

Comparison of the Pharmacokinetics, Bioequivalence and Safety of Aqueous Progesterone Formulation Administered as either Intramuscular or Subcutaneous Injection versus Oil-based Progesterone Formulation Administered as Intramuscular Injection: A Randomised Study
由: Sonal Mehta, et al.
出版: (2023-05-01)

DOX-Vit D, a Novel Doxorubicin Delivery Approach, Inhibits Human Osteosarcoma Cell Proliferation by Inducing Apoptosis While Inhibiting Akt and mTOR Signaling Pathways
由: Zaid H. Maayah, et al.
出版: (2018-09-01)

Recent Formulation Advances and Therapeutic Usefulness of Orally Disintegrating Tablets (ODTs)
由: Maimoona Chinwala
出版: (2020-10-01)

An Alternative Source of Biopesticides and Improvement in Their Formulation—Recent Advances
由: Dragana Šunjka, et al.
出版: (2022-11-01)

A clinically relevant combination treatment with doxorubicin and cyclophosphamide does not induce hepatotoxicity in C57BL/6J mice
由: Satyanarayana R Pondugula, et al.
出版: (2021-12-01)

Allicin and L-carnitine as Preventive Agents Against Doxorubicin-induced Cardiac Damage in Rats
由: Ahmed Soliman, et al.
出版: (2024-08-01)

Effect of Alkaline Conditions on Forming an Effective G4.0 PAMAM Complex with Doxorubicin
由: Magdalena Szota, et al.
出版: (2023-03-01)

What does Pesticide Formulation Have to Do with Anything?
由: Laurie Ann Hurner
出版: (2016-08-01)

EFFECT OF THE C60 FULLERENE, DOXORUBICIN AND THEIR COMPLEX ON CANCER AND NORMAL CELLS OF BALB/c MICE
由: Prylutska S. V., et al.
出版: (2014-02-01)

Research Progress on Oral Nano-formulation to Deliver Astaxanthin
由: Chen ZHONG, et al.
出版: (2024-05-01)

Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives
由: Soon-Seok Hong, et al.
出版: (2019-10-01)

Hesperidin as a preventive resistance agent in MCF–7 breast cancer cells line resistance to doxorubicin
由: Rifki Febriansah, et al.
出版: (2014-03-01)

Melatonin Restores Autophagic Flux by Activating the Sirt3/TFEB Signaling Pathway to Attenuate Doxorubicin-Induced Cardiomyopathy
由: Yanyan Ma, et al.
出版: (2023-09-01)

Metacommunication in the judiciary field: formulations. A proposal for cataloging and an approach to facework in institutional contexts
由: Laura Mariottini
出版: (2015-12-01)

Recent Advances in Propranolol Hydrochloride Formulations for the Treatment of Infantile Hemangiomas
由: Ren L, et al.
出版: (2025-02-01)

90-Days Repeated Dose Oral Toxicity Study of Sharbat-e-Deenar (A Hepatoprotective Unani Herbal Formulation)
由: Gulam Mohammed Husain, et al.
出版: (2021-03-01)

Exploitation of enrofloxacin-loaded docosanoic acid solid lipid nanoparticle suspension as oral and intramuscular sustained release formulations for pig
由: Yanfei Tao, et al.
出版: (2019-01-01)

A Novel Berberine–Glycyrrhizic Acid Complex Formulation Enhanced the Prevention Effect to Doxorubicin-Induced Cardiotoxicity by Pharmacokinetic Modulation of Berberine in Rats
由: Shichang Zhang, et al.
出版: (2022-07-01)

Development of Strategic Plan (Formulation, Implementation and Evaluation) of Physical Education in Lorestan Province by SWOT Approach
由: ahmadreza azizi, et al.
出版: (2020-06-01)

DHP107, a novel oral paclitaxel formulation induces less peripheral neuropathic pain and pain-related molecular alteration than intravenous paclitaxel preparation in rat
由: Md. Mahbubur Rahman, et al.
出版: (2019-08-01)

A clinical study to compare the efficacy and safety of pregabalin sustained release formulation with pregabalin immediate release formulation in patients of diabetic peripheral neuropathic pain
由: A Srivastava, et al.
出版: (2012-01-01)

Advances in Yeast Probiotic Production and Formulation for Preventative Health
由: Ghaneshree Moonsamy, et al.
出版: (2024-11-01)

Study of Oncolytic Virus Preservation and Formulation
由: Lina Pan, et al.
出版: (2023-06-01)

Pharmacokinetic and pharmacodynamic evaluation according to absorption differences in three formulations of ibuprofen
由: Shin D, et al.
出版: (2017-01-01)

Identification of co-regulated genes associated with doxorubicin resistance in the MCF-7/ADR cancer cell line
由: Ali Miri, et al.
出版: (2023-06-01)

Study of Marketing Strategy Formulation at Ok Clean Laundry using SWOT Analysis
由: Awal Muhammad, et al.
出版: (2022-01-01)

Influence of Differing Analgesic Formulations of Aspirin on Pharmacokinetic Parameters
由: Kunal Kanani, et al.
出版: (2015-08-01)

Inflammatory Reprogramming Mediates Changes in Three-Dimensional Strain Capacity and Cardiac Function in Beagle Dogs with Doxorubicin-Related Cardiomyopathy
由: Yifan Chen, et al.
出版: (2024-02-01)

Formulation Patents and Dermatology and Obviousness
由: Josephine Liu, et al.
出版: (2011-11-01)

Effectiveness of polyherbal formulations for the treatment of type 2 Diabetes mellitus - A systematic review and meta-analysis
由: Renuka Suvarna, et al.
出版: (2021-01-01)

Recent Advances in Nano-Formulations for Skin Wound Repair Applications
由: Lin Y, et al.
出版: (2022-08-01)

Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications
由: Hao Ji, et al.
出版: (2021-09-01)

Doxorubicin/Nucleophosmin Binding Protein-Conjugated Nanoparticle Enhances Anti-leukemia Activity in Acute Lymphoblastic Leukemia Cells in vitro and in vivo
由: Donghui Gan, et al.
出版: (2021-05-01)

Strategic Management Roadmap: Formulation, Implementation, and Evaluation to Develop Islamic Higher Education Institution
由: Junaidah Junaidah, et al.
出版: (2020-12-01)